Drawing for SEMDEXA

USPTO serial 97729579

SEMDEXA

Reviewed by CopyMark Law Group

Status 616
Filing date
Status date
Registration date
—
Examiner
RUIZ SANTIAGO, REBECCA E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SEMDEXA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pain relief medication; preparations for the relief of pain; injectable pharmaceutical gels for treatment of back pain, lumbosacral radicular pain and sciatica; pharmaceutical preparations, namely, dexamethasone sodium phosphate for medical use for use in the treatment of pain; pharmaceutical preparations, namely, dexamethasone sodium phosphate gel for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 1, 2026NREVNOTICE OF REVIVAL - E-MAILED—
Oct 1, 2026PETGPETITION TO REVIVE-GRANTED—
Oct 1, 2026PROATEAS PETITION TO REVIVE RECEIVED—
Jul 27, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 27, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 21, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 21, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 21, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 21, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 24, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 23, 2025EX4GSOU EXTENSION 4 GRANTED—
Dec 23, 2025EXT4SOU EXTENSION 4 FILED—
Dec 23, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 14, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 13, 2025EX3GSOU EXTENSION 3 GRANTED—
Jun 13, 2025EXT3SOU EXTENSION 3 FILED—
Jun 13, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 3, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 20, 2024EX2GSOU EXTENSION 2 GRANTED—
Nov 20, 2024EXT2SOU EXTENSION 2 FILED—
Nov 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 18, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2024EX1GSOU EXTENSION 1 GRANTED—
Jun 18, 2024EXT1SOU EXTENSION 1 FILED—
Jun 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 26, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 31, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 31, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 4, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Sep 26, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 25, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Sep 25, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 25, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 25, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 22, 2023DOCKASSIGNED TO EXAMINER—
Dec 27, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 26, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance